4HV-69073-25193
2 vaccinations
1 coded response
19 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 840 / UT
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Registered in v-safe
- 2021-01-07
- 2021-01-08
- 2021-01-09
-
2021-01-16
Survey response — day 14, dose 1MedDRA: Diarrhoea, Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Nausea and diarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-23
Dose 2 — Pfizer-BioNTech
- 2021-01-23
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-30
- 2021-02-06
- 2021-02-12
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-04-24
- 2021-07-25
- 2022-01-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Pfizer-BioNTech | |
| 2 | 2021-01-23 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | Unsuccessful |
Free text
Release 2 — day 14, dose 1
Symptoms: Nausea and diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release